MYLAN INSTITUTIONAL INC

Mylan Institutional Inc. specializes in the manufacturing of pharmaceutical preparations, focusing on the production of sterile and non-sterile drug products for institutional and clinical use. Their technical expertise lies in adhering to cGMP standards for active pharmaceutical ingredient formulation, quality control, and batch documentation, ensuring compliance with FDA and VA pharmacopeial requirements. The company’s specialization in hematological and specialty pharmaceuticals suggests advanced capabilities in aseptic processing, lyophilization, and controlled substance handling, tailored to meet the stringent demands of federal healthcare supply chains. Their ability to deliver complex drug formulations under Federal Supply Schedule contracts indicates a robust quality management system and validated manufacturing processes suitable for high-reliability government procurement. The Department of Veterans Affairs is the sole agency documented in their award history, with a recent contract under the Federal Supply Schedule for pharmaceuticals, hematological agents, and related therapeutics. This suggests a focused, long-term partnership centered on supplying essential medications to VA medical centers and outpatient clinics, likely including oncology, anticoagulants, and injectable formulations critical to veteran care. Mylan Institutional Inc. operates primarily within NAICS 325412, which encompasses the formulation and packaging of finished pharmaceutical products for institutional distribution. Their market positioning is niche, serving the specialized needs of government healthcare systems requiring compliant, high-volume drug manufacturing with strict traceability and regulatory documentation. As a 2L entity based in Rockford, Illinois, the company maintains a lean operational structure optimized for contract manufacturing. While no federal certifications are listed, their consistent delivery under FSS contracts implies established GMP compliance, FDA registration, and DEA licensing for controlled substances. Their geographic presence supports midwestern logistics networks, enabling reliable distribution to federal medical facilities across the region.